NCT02684240View on ClinicalTrials.gov

A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 11, 2018

Study Completion Date

April 11, 2018

Conditions
Tuberculosis
Interventions
DRUG

Nitazoxanide

nitazoxanide 1000 mg orally twice daily with food for 14 days

OTHER

Control

The control arm will receive WHO standard therapy for tuberculosis with isoniazid, rifampin, pyrazinamide, and ethambutol

Trial Locations (1)

Unknown

Les Centres GHESKIO, Port-au-Prince

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT02684240 - A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis | Biotech Hunter | Biotech Hunter